Scarica l'app Stockscreener
21.18
2.29%
0.475
Pre-mercato:
21.30
0.125
+0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Precedente Chiudi:
$20.70
Aprire:
$20.7
Volume 24 ore:
4.65M
Relative Volume:
0.56
Capitalizzazione di mercato:
$14.73B
Reddito:
$125.68M
Utile/perdita netta:
$4.81B
Rapporto P/E:
3.7478
EPS:
5.65
Flusso di cassa netto:
$-781.21M
1 W Prestazione:
+1.46%
1M Prestazione:
+6.57%
6M Prestazione:
+88.89%
1 anno Prestazione:
+74.86%
Intervallo 1D:
$20.53
$21.33
Intervallo di 1 settimana:
$19.96
$21.33
Portata 52W:
$8.73
$21.35
Roivant Sciences Ltd Stock (ROIV) Company Profile
Nome
Roivant Sciences Ltd
Settore
Industria
Telefono
441-295-5950
Indirizzo
7TH FLOOR, 50 BROADWAY, LONDON
Confronta ROIV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
21.18 | 14.40B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-02 | Iniziato | Citigroup | Buy |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2024-01-05 | Iniziato | Piper Sandler | Overweight |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-10-17 | Iniziato | Guggenheim | Buy |
| 2023-06-08 | Iniziato | BofA Securities | Neutral |
| 2022-10-27 | Iniziato | JP Morgan | Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Iniziato | Goldman | Buy |
| 2021-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-28 | Iniziato | Citigroup | Buy |
| 2021-10-26 | Iniziato | Cowen | Outperform |
| 2021-10-26 | Iniziato | Jefferies | Buy |
| 2021-10-26 | Iniziato | Truist | Buy |
Mostra tutto
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Why Roivant Sciences Ltd. stock could rally in 2025Dividend Hike & Weekly Breakout Watchlists - Newser
How Roivant Sciences Ltd. (87S) stock compares with market leadersJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Roivant Sciences Ltd. (87S) stock undervalued by metricsWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Will Roivant Sciences Ltd. stock recover faster than peers2025 Market Overview & Capital Efficiency Focused Strategies - Newser
How Roivant Sciences Ltd. (87S) stock trades after rate cutsM&A Rumor & High Win Rate Trade Tips - Newser
Is Roivant Sciences Ltd. stock safe for conservative investorsEarnings Miss & Weekly High Conviction Trade Ideas - Newser
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
Why analysts recommend Roivant Sciences Ltd. (87S) stockJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
Is Roivant Sciences Ltd. (87S) stock prepared for digital transitionWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Why Roivant Sciences Ltd. (87S) stock signals breakout potential2025 Dividend Review & Risk Managed Investment Strategies - Newser
Rhumbline Advisers Reduces Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
Swiss National Bank Lowers Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Loomis Sayles & Co. L P Sells 352,443 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
(ROIV) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
33,356 Shares in Roivant Sciences Ltd. $ROIV Acquired by Inceptionr LLC - MarketBeat
Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN
Volume Report: Why Roivant Sciences Ltd. stock could be next big winnerEarnings Miss & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Bank Watch: Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Reactions & Low Drawdown Momentum Ideas - moha.gov.vn
Te Ahumairangi Investment Management Ltd Increases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
SG Americas Securities LLC Has $489,000 Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Growth Report: Why Roivant Sciences Ltd. stock is in analyst buy zoneWeekly Risk Summary & Weekly Return Optimization Alerts - BỘ NỘI VỤ
Can Roivant Sciences Ltd. stock double in next 5 years2025 Technical Overview & Fast Exit and Entry Strategy Plans - BỘ NỘI VỤ
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
Top Growth Companies With Strong Insider Ownership For November 2025 - Yahoo Finance UK
Why Roivant Sciences Ltd. stock could be next big winnerWeekly Loss Report & Weekly High Return Opportunities - BỘ NỘI VỤ
QVT Financial LP Reduces Stake in Roivant Sciences Ltd - GuruFocus
[Form 4] Roivant Sciences Ltd. Insider Trading Activity - Stock Titan
CFO Pulik Surrenders 1,235 Of Roivant Sciences Ltd [ROIV] - TradingView
Indian-origin billionaire Vivek Ramaswamy’s 80% net worth surge is NOT all from US politics - financialexpress.com
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling By Investing.com - Investing.com Nigeria
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling - Investing.com Nigeria
Roivant Sciences Insider Sold Shares Worth $26,304,500, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences Ltd. (87S.SG) Q4 FY2025 earnings call transcript - Yahoo Finance
QVT Financial LP sells Roivant Sciences (ROIV) shares worth $26.3 million - Investing.com Nigeria
Roivant Sciences director Manchester sells $26.3m in shares By Investing.com - Investing.com Nigeria
QVT Financial LP sells Roivant Sciences (ROIV) shares worth $26.3 million By Investing.com - Investing.com South Africa
Roivant Sciences director Gold sells $26.3 million in shares By Investing.com - Investing.com Nigeria
Roivant Sciences director Gold sells $26.3 million in shares - Investing.com
Owner QVT Financial LP Sells 1,300,000 ($26.3M) Of Roivant Sciences Ltd [ROIV] - TradingView
Roivant Sciences Ltd. (ROIV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Roivant Sciences Ltd. (87S) stock return to pre crash levelsWeekly Investment Report & Reliable Entry Point Alerts - newser.com
How Roivant Sciences Ltd. stock reacts to oil pricesEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Roivant Sciences Ltd Azioni (ROIV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):